Sign in

CIK 0001434316

  • Non-accelerated filer
  • Smaller reporting company

FATE THERAPEUTICS INC

Sign in to watch
Ticker
FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
651311552
Phone
+1 858-875-1803
Business address
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,525
in 1 filing

Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Adawi Kamal −$14K Chief Financial Officer sold 7% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-07-01 TAHL CINDY General Counsel and Secretary Option exercise · Stock Option (Right to Buy) −27,685 22,315
2021-07-01 TAHL CINDY General Counsel and Secretary Option exercise · Stock Option (Right to Buy) −15,383 166,643
2021-06-14 Plavsic Mark Chief Technical Officer Grant or award +38,000 38,000
2021-06-14 Plavsic Mark Chief Technical Officer Grant or award · Stock Option (Right to Buy) +18,500 18,500
2021-06-14 Valamehr Bahram Chief Development Officer Option exercise +16,156 $2.90 $47K 111,896
2021-06-14 Valamehr Bahram Chief Development Officer Option exercise +8,844 $2.73 $24K 120,740
2021-06-14 Valamehr Bahram Chief Development Officer Sale −16,380 $89.11 $1.5M 104,360
2021-06-14 Valamehr Bahram Chief Development Officer Sale −8,220 $89.68 $737K 96,140
2021-06-14 Valamehr Bahram Chief Development Officer Sale −400 $90.76 $36K 95,740
2021-06-14 Valamehr Bahram Chief Development Officer Option exercise · Stock Option (Right to Buy) −16,156 0
2021-06-14 Valamehr Bahram Chief Development Officer Option exercise · Stock Option (Right to Buy) −8,844 111,156
2021-06-02 Redmile Group, LLC Director Grant or award +2,681 12,959,903
2021-06-02 Redmile Group, LLC Director Grant or award · Stock Option (Right to Buy) +4,334 4,334
2021-06-02 Lee Michael Stewart Director Grant or award +2,681 2,681
2021-06-02 Lee Michael Stewart Director Grant or award · Stock Option (Right to Buy) +4,334 4,334
2021-06-02 HERSHBERG ROBERT Director Grant or award +2,681 2,681
2021-06-02 HERSHBERG ROBERT Director Grant or award · Stock Option (Right to Buy) +4,334 4,334
2021-06-02 COUGHLIN TIMOTHY Director Grant or award +2,681 59,071
2021-06-02 COUGHLIN TIMOTHY Director Grant or award · Stock Option (Right to Buy) +4,334 4,334
2021-06-02 RASTETTER WILLIAM H Director Grant or award +2,681 2,681

Page 19 of 26 · 503 trades